137O Tucatinib vs placebo added to trastuzumab and capecitabine in previously treated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB)
Titel:
137O Tucatinib vs placebo added to trastuzumab and capecitabine in previously treated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB)
Auteur:
Curigliano, G. Murthy, R. Loi, S. Okines, A. Paplomata, E. Hamilton, E. Hurvitz, S.A. Cameron, D. Borges, V. Bedard, P. Oliveira, M. Jakobsen, E.H. Bachelot, T. Shachar, S.S. Mueller, V. Carey, L.A. Loibl, S. Feng, W. Walker, L.N. Winer, E.